This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Value investing strategies for beginners can set the foundation for successful investing. Learn the basics to make informed investment choices.
22,275 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Chinese automakers are shifting from passenger cars to commercial fleets, challenging Ford's margins and strategy. Th...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
As AI moves from training to deployment, the infrastructure behind inference could redefine winning investments. This...
Oil markets are volatile and opportunity-filled. This guide explains why here's prices surging right and shows practi...
When the stock market's "fear gauge" ticks higher, it often precedes a meaningful move. This guide explains what that...
A bold claim from a top energy chief has investors reassessing risk. This guide breaks down what a tight oil market c...
A feud in late-night TV isn’t just talk. It can echo through stocks, regulator moves, and your budget. Learn how to s...
Travel demand is returning, but 2026 presents varied challenges for United Airlines. This guide breaks down the Unite...
Apple’s shares tumbled after WWDC-style AI updates raised questions about iPhone upgrades and monetization. This guid...
A new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...